Seeing Is Believing
with an average price target of $10.15. This is a potential upside of $10.15 (0%) from yesterday's end of day stock price of $0.
Concert Pharmaceuticals's activity chart (see below) currently has 63 price targets and 47 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.78% with an average time for these price targets to be met of 272.56 days.
Most recent stock forecast was given by STEPHEN KIM from EVERCORE on 20-Jan-2023. First documented stock forecast 08-Jul-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$17
2 years 3 months 19 days ago
(20-Jan-2023)
0/1 (0%)
$10.12 (147.09%)
Buy
$25
2 years 3 months 20 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Buy
$17
$8.63 (103.11%)
$17
2 years 11 months 16 days ago
(23-May-2022)
1/6 (16.67%)
$12.9 (314.63%)
115
Buy
$10
$1.63 (19.47%)
$15
3 years 5 months 27 days ago
(12-Nov-2021)
0/3 (0%)
$6 (150.00%)
Buy
$9
3 years 7 months 1 days ago
(08-Oct-2021)
3/10 (30%)
$6.09 (209.28%)
392
What is CNCE (Concert Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CNCE (Concert Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CNCE (Concert Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most bullish on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most reserved on CNCE (Concert Pharmaceuticals)?